Bio-Trials provides clinical monitoring, clinical site coordination, regulatory support, study management and supply distribution services.
Jeff Thomis, president of global clinical development services for Quintiles, said: “The acquisition of Bio-Trials gives Quintiles an experienced, well-established team as well as access to an experienced network of independent investigators in the increasingly important Central American region. Our customers are increasingly including Central America as part of their global drug development program. The Bio-Trials team will be a welcome addition to our Latin America group.”